3) Maintenance is often harder than loss A common real-world failure mode is losing weight, then regaining because the underlying drivers (hunger signaling, food environment, stress response, sleep, strength habits) were never stabilized
The FTO variant (rs9939609) reveals genetic predisposition to weight gain and appetite regulation, while the MC4R variant (rs17782313) controls melanocortin-4 receptor function in appetite and energy expenditure
Ozempic is used off-label for weight loss and is FDA-approved for: Controlling blood sugar in people with type 2 diabetes mellitus Reducing the risk of major cardiovascular health problems, such as heart attack, stroke, and death in adults with type 2 diabetes and heart disease Wegovy is FDA-approved for: Chronic weight management in adults and children 12 years and older with obesity (BMI of 30 or greater) Adults who are overweight (BMI of 27 or greater) with at least one weight-related medical condition, such as type 2 diabetes, high blood pressure, or high cholesterol Reducing the risk of major cardiovascular health problems, such as heart attack, stroke, and death in adults with obesity or overweight and heart disease Rybelsus is FDA-approved for: Controlling blood sugar in people with type 2 diabetes mellitus For those without insurance, online options for semaglutide may offer a possible solution: 1
Tirzepatide reduces appetite, energy intake, and fat mass in people with T2D (abstract)
Long-term control of arterial blood pressure
Therefore, we conducted a target trial emulation using de-identified electronic health record (EHR) data from Optum Labs Data Warehouse (OLDW) to evaluate the long-term effectiveness and safety of GLP-1RA initiation in T1D
